| Τύπος | Ημερομηνία | Τίτλος | Δημιουργός | Πλήρες κείμενο |
| 2001 | Synthesis and study of a cyclic angiotensin II antagonist analogue reveals the role of pi*-pi* interactions in the C-terminal aromatic residue for agonist activity and its structure resemblance with AT(1) non-peptide antagonists | Polevaya, L.; Μαυρομούστακος, Θωμάς; Ζουμπουλάκης, Παναγιώτης; Grdadolnik, S. G.; Roumelioti, P.; Giatas, N.; Mutule, I.; Keivish, T.; Vlahakos, D. V.; Iliodromitis, E. K.; Kremastinos, D. T.; Matsoukas, J. | |
| 2001 | Structure elucidation and conformational properties of a novel bioactive clerodane diterpene using a combination of high field NMR spectroscopy, computational analysis and X-ray diffraction | Kolocouris, A.; Μαυρομούστακος, Θωμάς; Demetzos, C.; Terzis, A.; Grdadolnik, S. G. | |
| 2002 | Structure elucidation and conformational properties of eprosartan a non peptide Angiotensin II AT(1) antagonist | Ζουμπουλάκης, Παναγιώτης; Grdadolnik, S. G.; Matsoukas, J.; Μαυρομούστακος, Θωμάς | |
| 2002 | Design, synthesis and biological evaluation of cyclic Angiotensin II analogues with 3,5 side-chain bridges: Role of C-terminal aromatic residue and ring cluster for activity and implications in the drug design of AT1 non-peptide antagonists | Roumelioti, P.; Polevaya, L.; Ζουμπουλάκης, Παναγιώτης; Giatas, N.; Mutule, I.; Keivish, T.; Zoga, A.; Vlahakos, D.; Iliodromitis, E.; Kremastinos, D.; Grdadolnik, S. G.; Μαυρομούστακος, Θωμάς; Matsoukas, J. | |
| 2003 | Antileishmanial ring-substituted ether phospholipids | Avlonitis, N.; Lekka, E.; Detsi, A.; Κουφάκη, Μαρία; Καλογεροπούλου, Θεοδώρα; Scoulica, E.; Σιάπη, Ελένη; Kyrikou, I.; Μαυρομούστακος, Θωμάς; Tsotinis, A.; Grdadolnik, S. G.; Makriyannis, A. | |
| 2003 | Structural elucidation and conformational properties of the toxin paralysin beta-Ala-Tyr | Kyrikou, I.; Grdadolnik, S. G.; Tatari, M.; Poulos, C.; Μαυρομούστακος, Θωμάς | |
| 2003 | Conformational and biological studies for a pair of novel synthetic AT(1) antagonists: stereoelectronic requirements for antihypertensive efficacy | Ζουμπουλάκης, Παναγιώτης; Zoga, A.; Roumelioti, P.; Giatas, N.; Grdadolnik, S. G.; Iliodromitis, E.; Vlahakos, D.; Kremastinos, D.; Matsoukas, J. M.; Μαυρομούστακος, Θωμάς | |
| 2004 | Conformation and bioactivity. Design and discovery of novel antihypertensive drugs | Μαυρομούστακος, Θωμάς; Ζερβού, Μαρία; Ζουμπουλάκης, Παναγιώτης; Kyrikou, I.; Benetis, N. P.; Polevaya, L.; Roumelioti, P.; Giatas, N.; Zoga, A.; Minakakis, P. M.; Kolocouris, A.; Vlahakos, D.; Grdadolnik, S. G.; Matsoukas, J. | |
| 2005 | 2D NMR and conformational analysis of a prototype anti-tumour steroidal ester | Kapou, A.; Fousteris, M. A.; Nikolaropoulos, S. S.; Ζερβού, Μαρία; Grdadolnik, S. G.; Ζουμπουλάκης, Παναγιώτης; Kyrikou, L.; Μαυρομούστακος, Θωμάς | |
| 2006 | Comparison of proposed putative active conformations of myelin basic protein epitope 87-99 linear altered peptide ligands by spectroscopic and modelling studies: The role of positions 91 and 96 in T-cell receptor activation | Mantzourani, E. D.; Tselios, T. V.; Grdadolnik, S. G.; Platts, J. A.; Brancale, A.; Deraos, G. N.; Matsoukas, J. M.; Μαυρομούστακος, Θωμάς | |
| 2006 | A putative bioactive conformation for the altered peptide ligand of myelin basic protein and inhibitor of experimental autoimmune encephalomyelitis [Arg(91), Ala(96)] MBP87-99 | Mantzourani, E. D.; Tselios, T. V.; Grdadolnik, S. G.; Brancale, A.; Platts, J. A.; Matsoukas, J. M.; Μαυρομούστακος, Θωμάς | |
| 2006 | Structure elucidation and conformational study of V8 - A novel synthetic non peptide AT(1) antagonist | Ζουμπουλάκης, Παναγιώτης; Politi, A.; Grdadolnik, S. G.; Matsoukas, J.; Μαυρομούστακος, Θωμάς | |
